meditip

Newsletter

[No. 872] MFDS Conducts Its First International Joint Review of Pharmaceuticals with Overseas Regulatory Authorities, Including Europe

2026.07.10

https://blog.naver.com/meditip79/224324267081

Previous post

No previous posts available.

Next post

[No. 871] MFDS Selects 'Bio Challenger' Program to Support the Commercialization of Innovative Advanced Biopharmaceuticals